Page last updated: 2024-10-27

flecainide and Scleroderma, Systemic

flecainide has been researched along with Scleroderma, Systemic in 1 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Scleroderma, Systemic: A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Taieb, D1
Chauveau, S1
Khamis, W1
de Montmollin, N1
Sesé, L1
Duchemann, B1
Nunes, H1
Uzunhan, Y1

Other Studies

1 other study available for flecainide and Scleroderma, Systemic

ArticleYear
[A case of systemic sclerosis].
    Revue des maladies respiratoires, 2020, Volume: 37, Issue:4

    Topics: Aged; Autoantibodies; Cystadenocarcinoma, Serous; Female; Flecainide; Humans; Lung Diseases, Interst

2020